Sign inJoin waitlistJoin the waitlist

Herbert Newton

Medical Director, Brain Tumor Center, UH Seidman Cancer Center · Case Western Reserve University/University Hospitals Cleveland Medical Center

Credentials: · · · ·

History

Brain Tumor Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
Present
Brain Tumor Center · Case Western Reserve University
Present
Case Western Reserve University/University Hospitals Cleveland Medical Center
Present

Memorial Sloan Kettering Cancer Center
1988–1990
Neurology
University of Michigan
1985–1988
Erie County Medical Center
1984–1985
Roswell Park Cancer Institute
Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
1980–1984
University At Buffalo
1975–1979

Research

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal
Cancer Research · 2008 · 573 citations
Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina
Journal of Neurosurgery Spine · 2010 · Last of 7 authors · 147 citations
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Neuro-Oncology · 2016 · 146 citations

LJ
Larry Junck
10 papers
Antonio Chiocca
8 papers
MC
Marc Chamberlain
8 papers
Jana Portnow
7 papers
John McGregor
7 papers
RC
Robert Cavaliere
7 papers · 2 as a fellow
Allan Friedman
6 papers
Allen Sills
6 papers
DS
Dennis Shrieve
6 papers
Eric Bourekas
6 papers
Henry Brem
6 papers
Jeffrey Raizer
6 papers

Grants

Glioma Growth--Pathogenesis and Clinical Control
National Institute of Neurological Disorders and Stroke · P20
Project lead · Ohio State University

Clinical trials

Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Principal investigator · Completed · Phase 2
Ohio State University Comprehensive Cancer Center
2005–2011
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
Principal investigator · Completed · Phase 1, Phase 2
Ohio State University Comprehensive Cancer Center
2004–2008
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Site PI · Recruiting · Phase 2, Phase 3
Global Coalition for Adaptive Research
2019–2030